Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

Christine Gicquel(Inserm), Yves Le Bouc(Inserm), Xavier Bertagna, A Louvel, Martin Schlumberger(Université Paris-Saclay), J M Duclos, Éric Baudin(Institut Gustave Roussy), Joël Coste(Université Paris Cité), Y Chapuis, P.-F. Plouin, Jérôme Bertherat(Centre National de la Recherche Scientifique), J P Luton, Véronique Gaston(Inserm)
PubMed
September 15, 2001
Cited by 287

Related Papers

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
|Nature|1998|2.4k
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
|Nature|2002|2.1k
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
|Neuroendocrinology|2012|869
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698